Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Design and Synthesis of (+/-)-3-Deoxygericudranin A as an Antitumour Agent
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 최윤정 | - |
| dc.contributor.author | 심필종 | - |
| dc.contributor.author | 김희두 | - |
| dc.date.accessioned | 2023-12-18T08:31:34Z | - |
| dc.date.available | 2023-12-18T08:31:34Z | - |
| dc.date.issued | 1997-01 | - |
| dc.identifier.issn | 0377-9556 | - |
| dc.identifier.issn | 2383-9457 | - |
| dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/159160 | - |
| dc.description.abstract | (+/-)-3 Deoxygericudranin A was designed and synthesized for the development of novel antitumour agent and for the elucidation of the effect of 3-hydroxyl group in gericudranin A on antitumour activity. 2,4.6-Trihydroxyacetophenone was converted to 3-deoxygericudranin A in 5 steps via sequential protection, aldol condensation, Michael tvpe-cyclization, regioselective, C-benzylation and deprotection. | - |
| dc.format.extent | 4 | - |
| dc.language | 한국어 | - |
| dc.language.iso | KOR | - |
| dc.publisher | 대한약학회 | - |
| dc.title | Design and Synthesis of (+/-)-3-Deoxygericudranin A as an Antitumour Agent | - |
| dc.title.alternative | 항암제로서의 (+/-)-3-데옥시제리쿠드라닌 A의 설계 및 합성 | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.bibliographicCitation | 약 학 회 지, v.41, no.1, pp 14 - 17 | - |
| dc.citation.title | 약 학 회 지 | - |
| dc.citation.volume | 41 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 14 | - |
| dc.citation.endPage | 17 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | domestic | - |
| dc.identifier.url | https://scholar.kyobobook.co.kr/article/detail/4010024032855 | - |
- Files in This Item
- Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.